Christoph Merian-Ring 11
Vaxxilon AG is focused on the discovery and development of innovative synthetic carbohydrate vaccines. Headquartered near Basel, Switzerland with research labs in Berlin, the Vaxxilon team is advancing several vaccine candidates for the prevention of major infectious diseases.
CEO: Tom Monroe
CSO: Arne von Bonin
Please click here for Vaxxilon job opportunities.